HIV Remission: The Promise Of Protein Alpha-4 Beta-7 Integrin Antibody Treatment
A new study conducted by a team of scientists at the National Institutes of Health have recently found that the presence of the protein alpha-4 beta-7 integrin on the surface of HIV along with its monkey equivalent, which is the simian immunodeficiency virus, or SIV, may help explain why an antibody protected monkeys from SIV in previous experiments. Way back in October 2016, researchers have reported that they were able to achieve a sustained SIV remission in monkeys using a monkey antibody that is similar to the human drug vedolizumab, a type of drug that has been approved by the U.S. Food and Drug Administration for treating ulcerative colitis and Crohn's disease. Although it was previously unclear what type of mechanism is involved, a new report presented at the Conference on Retroviruses and Opportunistic Infections in Seattle provides clues.
Protein Alpha-4 Beta-7 Integrin And Its Properties
According to reports revealed by Science Daily, scientists have long noted that alpha-4 beta-7 integrin is a gut-homing receptor present at high levels on the immune-system cells that HIV and SIV preferentially infect. In fact, in the new study, it was found that maturing HIV and SIV particles acquire alpha-4 beta-7 as they emerge from an infected cell, which, in turn, has presented researchers with a new target for HIV prevention and treatment. Additionally, experts said that the findings have also paved the way for better understanding of how HIV disease develops.
Furthermore, in one of his statements reported by Specialty Pharmacy Times, Anthony S. Fauci, MD, director of the NIH's National Institute of Allergy and Infectious Diseases who also happens to be the study's co-author has said that the team initially expected the antibody to attach the alpha-4 beta-7 on immune cells and to consequently reduce their movement to the gut, where HIV and SIV typical decimate the cells early in infection. However, the findings obtained have shown that anti-alpha-4 beta-7 antibody binds not only to cells but also to HIV and SIV. Thus, experts believe that the process likely explains at least in part of the previous observation that SIV-infected monkeys treated with antibody to alpha-4 beta-7 and that an antiretroviral therapy controlled the virus very effectively long after all treatment ended.
Future Plans For HIV Treatment
Meanwhile, the team reveals that their next step is to allegedly conduct a study designed to prove that the presence of alpha-4 beta-7 on SIV explains the protective effect of the alpha-4 beta-7 antibody that was observed in the earlier monkey studies. As of the press time, the experts have highly emphasized that the current study findings basically suggest that the protein is crucial to the initial phase of infection, which has a major influence on the subsequent development of HIV.
Hope For HIV: Merck’s Drug For HIV Shows Promising Results
As the quest to eradicate the globally pandemic disease caused by HIV continues, how did Merck’s version of HIV drug fare in terms of effectiveness? Could it be the cure that a lot of people have been waiting for? What’s the truth behind claims that the alleged cure has been successful in its Phase 3 trial endpoint? Find out what the authorities have to say
The Power Of Cannabis Sheds Light In The Fight Against Brain Cancer
Considering that a lot of US’ states have been considering the legalization of cannabis and others have already been legalizing it, what’s the truth behind new claims that it can potentially be used as the secret weapon against brain cancer? Could it be the cure that can pave the way for other treatments involving cannabis? Find out what experts have to say about it
Ebola Update: This New Breakthrough ‘Scorecard’ Will To Make It Easier To Fight Ebola
As the Ebola scare is still being felt, how does researchers plan to eradicate this pandemic problem? What's the truth behind clams that an alleged 'scorecard' can potentially help scientists in their quest to end the disease? How essential could it get? Find out what experts have to say
HIV, The Next Target Of Trump Administration
As continuous efforts to eradicate HIV are taking place, why does the Trump administration wanted to halt the treatment that has been started by the previous government? What’s the truth behind claims that if the current US President would push this through, it will kill thousands? Find out what authorities have to say
How Do We Reduce HIV Risk? Here Are Experts' Tips
With the continuous efforts to eradicate one of the world's long dreaded disease, can we really do certain precautionary measures to prevent the risk of HIV? What are the necessary steps to prevent transmission of the disease? Find out what experts have to say
HIV Vaccine Cures Five Patients For Seven Months
New AIDS vaccine developed in Spain have reportedly cured 5 patients, helping them remain virus-free for seven months after taking the treatment. In the study, the treatment allowed the patients to stop taking regular antiretroviral (ARV) drugs to suppress HIV symptoms.
MORE IN ITECHPOST
It's the Perfect Time to Turn to FinTech
Money management has evolved in recent years. People aren't eager to make appointments at their local bank branch, and they're not organizing their monthly budget using the classic envelope system. They're leaving these dated activities behind and quickly embracing the variety of options offered by contemporary FinTech.
[Video] SpaceX Starship Prototype Explodes Ahead of Upcoming Historic Crewed Rocket Launch
Before the upcoming historic crewed rocket launch by SpaceX's Dragon, the Starship prototype exploded in Texas!
Sony Leaks Fortnite Chapter 2 Season 3: Spongebob Squarepants?
Sony leaks bits and pieces of the upcoming Fortnite Chapter 2 Season 3, could the next collab be with Spongebob Squarepants?